Relapsed and/or Refractory Lymphoma
Also known as: Relapsed or Refractory Lymphomas / Relapsed or Refractory Lymphoma
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00480 | Lenalidomide | A thalidomide derivative used to treat multiple myeloma and anemia in low to intermediate risk myelodysplastic syndrome. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00480 | Lenalidomide | Prostaglandin G/H synthase 2 | target |
| DB00480 | Lenalidomide | Tumor necrosis factor ligand superfamily member 11 | target |
| DB00480 | Lenalidomide | Cadherin-5 | target |
| DB00480 | Lenalidomide | Protein cereblon | target |
| DB00480 | Lenalidomide | P-glycoprotein 1 | transporter |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11891 | Fimepinostat | 1 | Completed | 1 |
| DB00196 | Fluconazole | 1 | Completed | 1 |
| DB01167 | Itraconazole | 1 | Completed | 2 |
| DB18006 | LP-284 | 1 | Recruiting | 1 |
| DB01129 | Rabeprazole | 1 | Completed | 2 |
| DB01045 | Rifampicin | 1 | Completed | 2 |
| DB00073 | Rituximab | 1 | Completed | 1 |
| DB11581 | Venetoclax | 1 | Completed | 1 |